Metallic nanoparticles as X-Ray computed tomography (CT) contrast agents: A review

MakaleYalnız künyeScopus SJRQ2
  • SDG 3 · Sağlık ve Kaliteli Yaşam

Özet

X-ray computed tomography vastly used in both medical purposes and in the research of biological and non-biological materials/samples. Some of the medical applications performed in the clinics requires special protocols where contrast agents may be needed to enhance the contrast. Iodine based contrast agents are commonly used in such applications. Iodine based contrast agents were found hazardous to the environment and some patients has iodine in tolerance due to thyroid origin diseases. Scientists from different fields try to develop contrast agents which can be an alternative to iodine based contrast agents. Metallic nanoparticles have potential to be used as CT contrast agent since metals has high X-ray attenuation and high density. Metal nanoparticles considered as toxic to the living organisms. Covering nanoparticles with organic molecule often reduce toxicity and enhance the biocompatibility. Decoration of nanoparticles with function groups give them targeting properties where special organ and/or tissue can be targeted. Up to now, different studies illustrated the importance of the multipurpose properties of the metallic nanoparticles. In this report, we assessed the metal nanoparticles reported as X-ray computed tomography contrast agent. For the first time in the literature we listed in vivo contrast enhancement, targeted drug delivery and dual/multipurpose imaging properties of each metallic nanoparticles. Therapeutic effects of metallic nanoparticles such as photothermal therapy and magnetic hyperthermia were also addressed. A chart showing relative contrast enhancement properties of the nanoparticles were produced.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/munzur/3837Resmi atıflarda kullanılan kalıcı adres
İndeks kayıtları
Kaydın indeks veri tabanlarındaki sayfası (aktarımda alınan kayıt numarasıyla). Erişim, indeksin kendi koşullarına bağlıdır.
Atıflar
Scopus
127
OpenAlex
134
Her kaynağın kendi saydığı toplam atıf; aktarım ve zenginleştirme sırasında alındı.
Tam Kayıt
AlanDeğerDil
dc.contributor.authorAslan, Naim
dc.contributor.authorCeylan, Burhan
dc.contributor.authorKoç, Mümin Mehmet
dc.contributor.authorFindik, Fehim
dc.date.accessioned2026-10-28T14:57:11.929589685Z
dc.date.available2026-10-28T14:57:11.929589685Z
dc.date.issued2020
dc.description.abstractX-ray computed tomography vastly used in both medical purposes and in the research of biological and non-biological materials/samples. Some of the medical applications performed in the clinics requires special protocols where contrast agents may be needed to enhance the contrast. Iodine based contrast agents are commonly used in such applications. Iodine based contrast agents were found hazardous to the environment and some patients has iodine in tolerance due to thyroid origin diseases. Scientists from different fields try to develop contrast agents which can be an alternative to iodine based contrast agents. Metallic nanoparticles have potential to be used as CT contrast agent since metals has high X-ray attenuation and high density. Metal nanoparticles considered as toxic to the living organisms. Covering nanoparticles with organic molecule often reduce toxicity and enhance the biocompatibility. Decoration of nanoparticles with function groups give them targeting properties where special organ and/or tissue can be targeted. Up to now, different studies illustrated the importance of the multipurpose properties of the metallic nanoparticles. In this report, we assessed the metal nanoparticles reported as X-ray computed tomography contrast agent. For the first time in the literature we listed in vivo contrast enhancement, targeted drug delivery and dual/multipurpose imaging properties of each metallic nanoparticles. Therapeutic effects of metallic nanoparticles such as photothermal therapy and magnetic hyperthermia were also addressed. A chart showing relative contrast enhancement properties of the nanoparticles were produced.
dc.identifier.articlenumber128599
dc.identifier.doi10.1016/j.molstruc.2020.128599
dc.identifier.eissn1872-8014
dc.identifier.issn0022-2860
dc.identifier.scopus2-s2.0-85086378790
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/munzur/3837
dc.identifier.volume1219
dc.identifier.wosWOS:000569383000007
dc.language.isoen
dc.publisherElsevier B.V.
dc.relation.ispartofJournal of Molecular Structure
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectBismuth nanoparticles
dc.subjectComputed tomography
dc.subjectCT/MRI
dc.subjectGold nanoparticles
dc.subjectMetal nanoparticles
dc.subjectMultimodal imaging
dc.subject.otherBiocompatibility
dc.subject.otherBiological materials
dc.subject.otherBiology
dc.subject.otherComputerized tomography
dc.subject.otherHyperthermia therapy
dc.subject.otherIodine
dc.subject.otherMedical applications
dc.subject.otherMetal nanoparticles
dc.subject.otherMetals
dc.subject.otherNanomagnetics
dc.subject.otherX rays
dc.subject.otherContrast Enhancement
dc.subject.otherImaging properties
dc.subject.otherMagnetic hyperthermia
dc.subject.otherMetallic nanoparticles
dc.subject.otherPhotothermal therapy
dc.subject.otherTherapeutic effects
dc.subject.otherX-ray attenuation
dc.subject.otherX-ray computed tomography
dc.subject.otherTargeted drug delivery
dc.titleMetallic nanoparticles as X-Ray computed tomography (CT) contrast agents: A review
dc.typeArticle
rdl.citation.openalex134
rdl.citation.scopus127
rdl.oa.statusclosed
rdl.scopus.quartileQ2
rdl.sdgSDG03
rdl.source.indexSCOPUS
rdl.source.indexWOS